Sign up for the QMED & MD+DI Daily newsletter.
Lack of Recognition is Part of the Problem
At least when it comes to treating abdominal aortic aneurysms (AAA). Did you know that deaths as a result of AAA are just as common as those from prostate and breast cancer? New tools are raising the bar in terms of what doctors can do, making good surgeons excellent and excellent surgeons phenomenal ones, according to Mark Farber, a physician who spoke at a media and investor event held by Cook Medical yesterday afternoon in New York City.Cook is one of three major companies leading the way in treating AAA.
November 16, 2007
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "Lack of Recognition is Part of the Problem")
In fact, the company has exceeded its own expectations in global sales this year and now leads the worldwide market in endovascular aortic repair. By the end of the third quarter, Cook surpassed Gore and captured 40% of the U.S. market (Gore had 35% and Medtronic held 23%). In Europe, Cook took the top spot in AAA stent grafts at 42%. The company is working on several projects for its Zenith Endograft product family for 2008. We can expect to see several clinical trials, PMA submissions, and even product launches in the coming year as Cook tries to keep a tight grip on the market.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
